• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床实验室中低分子量肝素的测定

Determination of low molecular weight heparin in clinical laboratory.

作者信息

van Putten J, van de Ruit M, Beunis M, Hemker H C

出版信息

Haemostasis. 1984;14(2):205-10. doi: 10.1159/000215057.

DOI:10.1159/000215057
PMID:6203817
Abstract

The applicability was investigated of automated spectrophotometric heparin assays and three clotting assays for determination of two low molecular weight (LMW) heparin fractions: Org 10172 and DxN10 and two infractionated commercially available heparins. The relative activity of the two commercially available heparins was similar in the anti-Xa assay, in the anti-IIa assay and in 3 clotting assays. The LMW heparins showed markedly different relative activity in all 5 assays. The activities of those heparin preparations relative to the standard heparin were compared in the 5 assays, but standardization against a standard heparin preparation appeared impossible. Methods of heparin determination can be used to monitor treatment with a heparin preparation only if the same preparation is used as a reference substance.

摘要

研究了自动分光光度法肝素测定法和三种凝血测定法在测定两种低分子量(LMW)肝素制剂(Org 10172和DxN10)以及两种市售分级肝素中的适用性。两种市售肝素在抗Xa测定、抗IIa测定和三种凝血测定中的相对活性相似。低分子量肝素在所有五种测定中显示出明显不同的相对活性。在这五种测定中比较了这些肝素制剂相对于标准肝素的活性,但以标准肝素制剂进行标准化似乎是不可能的。只有当使用相同的制剂作为参考物质时,肝素测定方法才能用于监测肝素制剂的治疗。

相似文献

1
Determination of low molecular weight heparin in clinical laboratory.临床实验室中低分子量肝素的测定
Haemostasis. 1984;14(2):205-10. doi: 10.1159/000215057.
2
Automated amidolytic method for determining heparin, a heparinoid, and a low-Mr heparin fragment, based on their anti-Xa activity.基于肝素、类肝素和低分子肝素片段的抗Xa活性,用于测定它们的自动化酰胺分解法。
Clin Chem. 1984 Jun;30(6):860-4.
3
A cross-over comparison of the anti-clotting effects of three low molecular weight heparins and glycosaminoglycuronan.三种低分子量肝素与糖胺聚糖抗凝血作用的交叉比较。
Br J Clin Pharmacol. 1993 Jul;36(1):51-6. doi: 10.1111/j.1365-2125.1993.tb05891.x.
4
Synopsis of the anticoagulant and antithrombotic profile of the low molecular weight heparinoid Org 10172 in experimental models.低分子量类肝素Org 10172在实验模型中的抗凝和抗血栓特性概要
Semin Thromb Hemost. 1989 Oct;15(4):370-2. doi: 10.1055/s-2007-1002732.
5
Normal and low molecular weight heparins: interaction with human platelets.普通肝素和低分子量肝素:与人类血小板的相互作用。
Eur J Clin Invest. 1983 Apr;13(2):135-9. doi: 10.1111/j.1365-2362.1983.tb00078.x.
6
Automated spectrophotometric heparin assays. Comparison of methods.自动分光光度法肝素测定。方法比较。
Haemostasis. 1984;14(2):195-204. doi: 10.1159/000215056.
7
Clinical use of heparin fractions, fragments, and heparinoids.肝素片段、碎片及类肝素的临床应用。
Semin Thromb Hemost. 1985 Apr;11(2):208-12. doi: 10.1055/s-2007-1004376.
8
Anticoagulant mechanisms of Orgaran (Org 10172) and its fraction with high affinity to antithrombin III (Org 10849).奥加诺(Org 10172)及其与抗凝血酶III高亲和力组分(Org 10849)的抗凝机制。
Haemostasis. 1992;22(2):66-72. doi: 10.1159/000216297.
9
Orgaran (Org 10172): its pharmacological profile in experimental models.奥曲肽(Org 10172):其在实验模型中的药理学特性。
Haemostasis. 1992;22(2):58-65. doi: 10.1159/000216296.
10
Development of a fluorescent anti-factor Xa assay to monitor unfractionated and low molecular weight heparins.开发荧光抗因子 Xa 测定法以监测未分级和低分子量肝素。
Talanta. 2010 Jun 15;81(4-5):1725-30. doi: 10.1016/j.talanta.2010.03.030. Epub 2010 Mar 25.

引用本文的文献

1
Increased fibrinolysis increases bleeding in orthopedic patients receiving prophylactic fondaparinux.在接受预防性磺达肝素钠治疗的骨科患者中,纤维蛋白溶解增加会增加出血风险。
Int J Hematol. 2012 Feb;95(2):160-6. doi: 10.1007/s12185-012-1004-2. Epub 2012 Jan 21.
2
Monitoring for anti-Xa activity for prophylactic administration of Fondaparinux in patients with artificial joint replacement.监测人工关节置换患者中预防性使用磺达肝素的抗 Xa 活性。
Int J Hematol. 2011 Oct;94(4):355-360. doi: 10.1007/s12185-011-0933-5. Epub 2011 Sep 22.